MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 24 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,459,000 | +11.2% | 2,876,000 | 0.0% | 0.01% | +20.0% |
| Q2 2017 | $2,211,000 | -8.3% | 2,876,000 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $2,410,000 | -9.9% | 2,876,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $2,675,000 | -28.0% | 2,876,000 | -2.0% | 0.01% | -33.3% |
| Q3 2016 | $3,715,000 | +11.1% | 2,936,000 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $3,343,000 | -38.4% | 2,936,000 | -19.6% | 0.01% | -38.5% |
| Q1 2016 | $5,423,000 | +18.1% | 3,652,000 | +17.7% | 0.01% | +30.0% |
| Q4 2015 | $4,593,000 | -3.3% | 3,102,000 | +2.8% | 0.01% | -9.1% |
| Q3 2015 | $4,748,000 | -24.9% | 3,018,000 | 0.0% | 0.01% | -15.4% |
| Q2 2015 | $6,326,000 | -19.9% | 3,018,000 | -24.6% | 0.01% | -18.8% |
| Q1 2015 | $7,900,000 | -13.9% | 4,005,000 | -16.7% | 0.02% | -15.8% |
| Q4 2014 | $9,172,000 | +18.0% | 4,810,000 | -3.8% | 0.02% | +18.8% |
| Q3 2014 | $7,772,000 | +17.4% | 5,000,000 | 0.0% | 0.02% | +14.3% |
| Q2 2014 | $6,618,000 | +30.9% | 5,000,000 | 0.0% | 0.01% | +27.3% |
| Q1 2014 | $5,057,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|